|Multiple Myeloma (MM) is the second most common cancer of the blood and accounts for 1% of all malignancies. MM is a very heterogeneous disease from both clinical and molecular point of view. Its pathogenesis remains poorly understood and it is considered an incurable disease. The molecular epidemiology of MM is an exciting area of research. Major advances have been made in recent years highlighting the need to face the disease through common efforts within large cooperative groups. Multiple Myeloma is a progressive and debilitating B-cell disorder typified by the accumulation and dissemination of malignant plasma cells in the bone marrow which subsequently induce osteolytic lesions. Despite recent advancement of new therapies for MM, patients ultimately develop drug resistance and succumb to the disease. The top journals are peer reviewed scholarly journals. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in MEDLINE, PUBMED, SCOPUS, COPERNICUS, CAS, EBSCO and ISI.